Sarepta Therapeutics, Inc. — Director's Dealing 2011

Sep 3, 2011

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AVI BIOPHARMA INC (AVII)
CIK: 0000873303
Period of Report: 2011-08-31

Reporting Person: Toshav Bracha Ephrat (Sr VP & General Counsel)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2011-08-31	Stock Option (right to buy)	$1.24	A	150000	Acquired	2021-08-31	Common Stock (150000)	Direct

Footnotes

F1: This option is exercisable at the rate of 25% of the shares on August 31, 2012 and 1/48th of the total granted shares on each monthly anniversary thereafter, such that the option will be fully exercisable on August 31, 2015.